仙琚制药：醋酸地塞米松片通过一致性评价

Core Viewpoint - Xianju Pharmaceutical (002332.SZ) has received approval from the National Medical Products Administration for its Acetate Dexamethasone Tablets, which have passed the consistency evaluation of quality and efficacy for generic drugs [1] Group 1: Product Approval - The company has obtained the "Drug Supplement Application Approval Notice" for Acetate Dexamethasone Tablets, with the notice number 2025B03820 [1] - Acetate Dexamethasone Tablets are classified as corticosteroids and are primarily used for allergic and autoimmune inflammatory diseases [1] Group 2: Indications - The drug is indicated for conditions such as connective tissue diseases, severe bronchial asthma, dermatitis, ulcerative colitis, acute leukemia, and malignant lymphoma [1]